arrow
S

Susan J. Connor

university of adelaide
H指数:31
被引数:5,250

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Australian Real-World Effectiveness and Safety of Ustekinumab for the Treatment of Crohn's Disease: Results of the AURORA Study, Including the ANZIBD Consortium

澳大利亚真实世界ustekinumab治疗克罗恩病的有效性与安全性:AURORA研究的结果,包括ANZIBD联盟

2025-12-090
OAAI
Low Rates of Surgical Recurrence Following Ileocolic Resections for Crohn's Disease in the Biologic Era

生物制剂时代克罗恩病回结肠切除术后手术复发率低

2025-12-010
PRE
Transcriptomic signatures of host immune responses in aphthous ulcers, the earliest lesions of Crohn's disease, suggest that bacterial uptake, rather than global dysbiosis, is the initiating factor

复发性口疮(克罗恩病最早期的病变)宿主免疫反应的转录组特征表明,细菌摄取而非全局菌群失调是起始因素。

2025-05-190
OA
Diagnosis and Management of Upper Gastrointestinal Involvement in Adult Patients With Crohn’s Disease: A Systematic Review

Cohen, N.A.; Sror, N.; Naseer, M.; Bettenworth, D.; Lu, C.; Khedraki, R.; Abreu, M.; Atreya, R.; Al-Bawardy, B.; Connor, S.J.; 等. 成人克罗恩病患者上消化道受累的诊断与管理:一项系统综述. Clin. Gastroenterol. Hepatol. 2025, 即将出版. [Google Scholar] [CrossRef] [PubMed]

2025-05-140
PRE
Optimizing 5-aminosalicylate for moderate ulcerative colitis: expert recommendations from the Asia-Pacific, Middle East, and Africa Inflammatory Bowel Disease Coalition
2025-01-301
OAAI
Impaired health-related quality of life is associated with alterations in gut microbiota signatures in patients with Inflammatory Bowel Disease: baseline data from the Australian IBD Microbiome study
2025-01-220
PRE